Asymchem Laboratories (Tianjin) Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Asymchem Laboratories (Tianjin) kazanç ve gelirin sırasıyla yıllık 32.6% ve 19% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 31.1% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 8.8% olacağı tahmin edilmektedir.

Anahtar bilgiler

32.6%

Kazanç büyüme oranı

31.1%

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi	19.3%
Gelir büyüme oranı	19.0%
Gelecekteki özkaynak getirisi	8.8%
Analist kapsamı	Good
Son güncelleme	31 Oct 2024

Gelecekteki son büyüme güncellemeleri

Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Just Missed Earnings: Here's What Analysts Think Will Happen Next

Apr 03

Recent updates

Estimating The Intrinsic Value Of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821)

Oct 15

Investors Still Aren't Entirely Convinced By Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Earnings Despite 25% Price Jump

Sep 28

Is There An Opportunity With Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) 49% Undervaluation?

Jul 16

Asymchem Laboratories (Tianjin) (SZSE:002821) Is Paying Out A Dividend Of CN¥1.80

Jun 27

Benign Growth For Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Underpins Its Share Price

Jun 26

Does Asymchem Laboratories (Tianjin) (SZSE:002821) Have A Healthy Balance Sheet?

May 22

Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Just Missed Earnings: Here's What Analysts Think Will Happen Next

Apr 03

Downgrade: Here's How Analysts See Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Performing In The Near Term

Apr 02

A Look At The Fair Value Of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821)

Mar 26

Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Mar 04

Kazanç ve Gelir Büyüme Tahminleri

SZSE:002821 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	8,805	1,847	907	2,176	15
12/31/2025	7,311	1,535	736	1,567	16
12/31/2024	5,878	1,009	1,182	1,617	4
9/30/2024	5,571	769	427	1,738	N/A
6/30/2024	5,901	1,082	805	2,170	N/A
3/31/2024	6,976	1,920	1,481	2,737	N/A
12/31/2023	7,825	2,269	2,308	3,550	N/A
9/30/2023	8,801	2,791	1,958	3,312	N/A
6/30/2023	9,836	3,248	3,244	4,908	N/A
3/31/2023	10,445	3,433	2,543	4,386	N/A
1/1/2023	10,255	3,302	1,136	3,287	N/A
9/30/2022	9,508	3,094	452	2,606	N/A
6/30/2022	7,918	2,382	-1,834	267	N/A
3/31/2022	5,915	1,413	-1,832	217	N/A
12/31/2021	4,632	1,068	-1,547	113	N/A
9/30/2021	3,977	908	-986	572	N/A
6/30/2021	3,626	830	-391	916	N/A
3/31/2021	3,438	766	-514	624	N/A
12/31/2020	3,137	719	-442	573	N/A
9/30/2020	2,800	694	-72	596	N/A
6/30/2020	2,633	640	51	582	N/A
3/31/2020	2,459	570	92	574	N/A
12/31/2019	2,460	554	90	601	N/A
9/30/2019	2,372	534	-61	493	N/A
6/30/2019	2,170	501	-236	309	N/A
3/31/2019	1,948	457	-222	351	N/A
12/31/2018	1,835	428	-128	415	N/A
9/30/2018	1,732	401	-287	223	N/A
6/30/2018	1,629	373	N/A	306	N/A
3/31/2018	1,497	356	N/A	181	N/A
12/31/2017	1,423	341	N/A	196	N/A
9/30/2017	1,213	265	N/A	277	N/A
6/30/2017	1,184	289	N/A	338	N/A
3/31/2017	1,207	269	N/A	372	N/A
12/31/2016	1,103	253	N/A	278	N/A
9/30/2016	1,097	260	N/A	285	N/A
12/31/2015	831	154	N/A	257	N/A
12/31/2014	716	102	N/A	127	N/A
12/31/2013	543	75	N/A	106	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 002821 'nin tahmini kazanç büyümesi (yıllık 32.6% ) tasarruf oranının ( 2.9% ) üzerindedir.

Kazançlar ve Piyasa: 002821 şirketinin kazançlarının (yıllık 32.6% ) CN pazarından (yıllık 25.8% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: 002821 şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: 002821 şirketinin gelirinin (yıllık 19% ) CN pazarından (yıllık 14.1% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: 002821 şirketinin gelirinin (yıllık 19% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 002821 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 8.8 %).

Asymchem Laboratories (Tianjin) Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Price target decreased by 8.9% to CN¥87.14

Consensus EPS estimates fall by 17%

Price target decreased by 10% to CN¥103

Consensus revenue estimates fall by 21%

Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Just Missed Earnings: Here's What Analysts Think Will Happen Next

Price target decreased by 10% to CN¥137

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.61 (vs CN¥1.45 in 3Q 2023)

Estimating The Intrinsic Value Of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821)

Investor sentiment deteriorates as stock falls 19%

Executive VP & Executive Director recently bought CN¥1.8m worth of stock

Asymchem Laboratories (Tianjin) Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investors Still Aren't Entirely Convinced By Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Earnings Despite 25% Price Jump

Investor sentiment improves as stock rises 19%

CFO, Senior VP & Executive Director recently bought CN¥4.3m worth of stock

Price target decreased by 8.9% to CN¥87.14

Second quarter 2024 earnings released: EPS: CN¥0.64 (vs CN¥2.94 in 2Q 2023)

Is There An Opportunity With Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) 49% Undervaluation?

Asymchem Laboratories (Tianjin) Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024

Asymchem Laboratories (Tianjin) (SZSE:002821) Is Paying Out A Dividend Of CN¥1.80

Dividend of CN¥1.80 announced

Benign Growth For Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Underpins Its Share Price

Asymchem Appoints Cheng Yi Chen as CTO of Small-Molecule Sector

Asymchem Laboratories (Tianjin) Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 28 June 2024

Asymchem Laboratories (Tianjin) Co., Ltd. Approves Final Ordinary Dividend for the Year Ended 31 December 2023, Payable on 12 July 2024

Asymchem Appoints Franck Mevellec as Senior Director, Business Development

Does Asymchem Laboratories (Tianjin) (SZSE:002821) Have A Healthy Balance Sheet?

Consensus EPS estimates fall by 17%

Price target decreased by 10% to CN¥103

First quarter 2024 earnings released: EPS: CN¥0.76 (vs CN¥1.72 in 1Q 2023)

Consensus revenue estimates fall by 21%

Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Just Missed Earnings: Here's What Analysts Think Will Happen Next

Downgrade: Here's How Analysts See Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Performing In The Near Term

Price target decreased by 10% to CN¥137

Asymchem Laboratories (Tianjin) Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Asymchem Laboratories (Tianjin) Co., Ltd., Annual General Meeting, Jun 06, 2024

Asymchem Laboratories (Tianjin) Co., Ltd. Proposes Final Ordinary Dividend for the Year Ended 31 December 2023

A Look At The Fair Value Of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821)

Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) commences an Equity Buyback Plan for CNY 1,200 million worth of its shares, under the authorization approved on February 29,2024.

Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Price target decreased by 7.0% to CN¥153

Asymchem Laboratories (Tianjin) Co., Ltd. Appoints Hou Xinyi as an Independent Non-Executive Director, Effective 29 February 2024

Asymchem Laboratories (Tianjin) Co., Ltd. Announces Resignation of Wang Qingsong as Independent Non-Executive Director and Committees

Asymchem Laboratories (Tianjin) Co., Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024

Now 23% undervalued after recent price drop

New minor risk - Share price stability

Price target increased by 7.3% to CN¥170

Price target increased by 8.7% to CN¥169

Third quarter 2023 earnings released: EPS: CN¥1.45 (vs CN¥2.71 in 3Q 2022)

Asymchem Laboratories (Tianjin) Co., Ltd. Appoints Sun Xuejiao as Independent Non-Executive Director

New major risk - Revenue and earnings growth

Second quarter 2023 earnings released: EPS: CN¥2.94 (vs CN¥3.39 in 2Q 2022)

Asymchem Laboratories (Tianjin) Co., Ltd. Implements Final Cash Dividend (A shares) for 2022, Payable on 21 July 2023

Asymchem Laboratories (Tianjin) Co., Ltd. Declares Final Dividend for the Year Ended 31 December 2022. Payable on 21 July 2023

Consensus revenue estimates fall by 14%

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Asymchem Laboratories (Tianjin) Co., Ltd. to Report Fiscal Year 2022 Results on Mar 31, 2023

Asymchem Laboratories (Tianjin) Co., Ltd. Announces Resignation of Zhang Kun as an Independent Non-Executive Director

Price target decreased to CN¥192

Less than half of directors are independent

Consensus forecasts updated

Price target decreased to CN¥209

Third quarter 2022 earnings released: EPS: CN¥2.71 (vs CN¥0.79 in 3Q 2021)

Price target decreased to CN¥228

Price target decreased to CN¥253

Investor sentiment deteriorated over the past week

Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) commences an Equity Buyback Plan for CNY 800 million worth of its shares, under the authorization approved on September 2, 2022.

Price target decreased to CN¥264

Second quarter 2022 earnings released: EPS: CN¥3.38 (vs CN¥0.81 in 2Q 2021)

Asymchem Laboratories (Tianjin) Co., Ltd. to Report First Half, 2022 Results on Aug 25, 2022

Asymchem Laboratories (Tianjin) Co., Ltd. Provides Earnings Guidance for the Period Ended June 30, 2022

Price target decreased to CN¥354

Now 22% undervalued after recent price drop

Asymchem Laboratories (Tianjin) Co., Ltd. Approves Cash Dividend for the Year 2021

Now 21% undervalued after recent price drop

Asymchem Laboratories (Tianjin) Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2021, Payable on 21 July 2022